FDA Panel Recommends Label Change for Low T Usage
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. There could be major changes ahead in the prescribing recommendations for drugs that treat low testosterone. A blue-ribbon expert panel voted overwhelmingly on Wednesday for the Food and Drug Administration to impose strict new limitations on the multibillion-dollar testosterone drug industry,
Read More